A study from Northwestern Medicine highlights how glioblastoma, a highly aggressive brain tumor, exhibits varying genetic structures across different regions within a single tumor and between patients. Utilizing Hi-C sequencing, researchers revealed that glioblastoma genomes differ significantly from normal samples, showcasing glioblastoma-specific folding patterns. This variability contributes to the tumor's treatment resistance, leading to devastating survival rates; the five-year survival rate stands at 6.9% despite evolving therapeutic strategies. This research underscores the urgent need for personalized treatment approaches to address the unique genetic profiles of glioblastoma tumors.
Glioblastoma tumors exhibit dramatic variations in their genetic makeup and structure across different regions, complicating treatment efforts and emphasizing their treatment-resistant characteristics.
The researchers utilized Hi-C sequencing on glioblastoma patient samples, revealing diverse genome structures that complicate the treatment of this aggressive brain tumor.
Collection
[
|
...
]